Madison Investment Advisors LLC Buys Shares of 8,032 Humana Inc. (NYSE:HUM)

Madison Investment Advisors LLC acquired a new position in Humana Inc. (NYSE:HUM - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 8,032 shares of the insurance provider's stock, valued at approximately $2,038,000.

Several other institutional investors have also recently modified their holdings of the company. FPC Investment Advisory Inc. bought a new position in Humana during the fourth quarter valued at approximately $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana during the 4th quarter valued at $30,000. LFA Lugano Financial Advisors SA raised its position in Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after purchasing an additional 45 shares during the period. OFI Invest Asset Management bought a new stake in Humana in the fourth quarter worth $33,000. Finally, Atwood & Palmer Inc. lifted its stake in Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HUM. Piper Sandler raised their price objective on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. JPMorgan Chase & Co. decreased their price target on Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Truist Financial increased their price objective on Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research note on Monday, January 6th. Barclays lifted their target price on shares of Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research note on Thursday, February 13th. Finally, StockNews.com lowered Humana from a "buy" rating to a "hold" rating in a research report on Tuesday, March 18th. Eighteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $285.68.

Remove Ads

Humana Stock Down 1.3 %

Shares of HUM traded down $3.50 during mid-day trading on Wednesday, reaching $270.27. The company had a trading volume of 822,576 shares, compared to its average volume of 1,711,908. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company has a market capitalization of $32.62 billion, a price-to-earnings ratio of 27.16, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. The firm has a 50-day moving average price of $270.83 and a 200 day moving average price of $275.00.

Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. On average, sell-side analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.31%. Humana's dividend payout ratio is presently 35.58%.

Insider Activity

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.37% of the company's stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.